GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CKD Bio Corp (XKRX:063160) » Definitions » E10

CKD Bio (XKRX:063160) E10 : ₩227.32 (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is CKD Bio E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

CKD Bio's adjusted earnings per share data for the three months ended in Mar. 2024 was ₩516.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₩227.32 for the trailing ten years ended in Mar. 2024.

During the past 12 months, CKD Bio's average E10 Growth Rate was -60.60% per year. During the past 3 years, the average E10 Growth Rate was -49.20% per year. During the past 5 years, the average E10 Growth Rate was -32.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of CKD Bio was 2.80% per year. The lowest was -49.20% per year. And the median was -13.70% per year.

As of today (2024-06-05), CKD Bio's current stock price is ₩22350.00. CKD Bio's E10 for the quarter that ended in Mar. 2024 was ₩227.32. CKD Bio's Shiller PE Ratio of today is 98.32.

During the past 13 years, the highest Shiller PE Ratio of CKD Bio was 141.64. The lowest was 10.62. And the median was 27.67.


CKD Bio E10 Historical Data

The historical data trend for CKD Bio's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CKD Bio E10 Chart

CKD Bio Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,531.21 1,353.21 1,047.96 637.77 177.21

CKD Bio Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 576.27 443.99 322.88 177.21 227.32

Competitive Comparison of CKD Bio's E10

For the Drug Manufacturers - Specialty & Generic subindustry, CKD Bio's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CKD Bio's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CKD Bio's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where CKD Bio's Shiller PE Ratio falls into.



CKD Bio E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, CKD Bio's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=516/118.8477*118.8477
=516.000

Current CPI (Mar. 2024) = 118.8477.

CKD Bio Quarterly Data

per share eps CPI Adj_EPS
201406 -151.429 99.353 -181.142
201409 -36.191 99.608 -43.181
201412 -30.476 99.098 -36.550
201503 137.143 99.720 163.449
201506 157.143 100.050 186.668
201509 542.857 100.110 644.464
201512 398.095 100.220 472.088
201603 602.857 100.560 712.492
201606 571.429 100.790 673.807
201609 236.190 101.460 276.667
201612 341.905 101.560 400.105
201703 403.810 102.850 466.620
201706 444.762 102.610 515.144
201709 475.238 103.490 545.762
201712 164.762 102.990 190.131
201803 402.857 104.100 459.929
201806 305.714 104.130 348.924
201809 440.000 105.650 494.964
201812 328.571 104.350 374.220
201903 425.714 104.490 484.210
201906 588.571 104.880 666.956
201909 618.095 105.200 698.281
201912 757.667 105.120 856.611
202003 460.000 105.540 518.002
202006 624.000 104.870 707.170
202009 252.000 106.200 282.011
202012 -189.000 105.765 -212.378
202103 -357.000 107.357 -395.210
202106 87.000 107.579 96.113
202109 -777.000 108.759 -849.074
202112 -152.000 109.676 -164.710
202203 -220.000 111.806 -233.856
202206 -897.000 114.083 -934.465
202209 -638.000 114.831 -660.315
202212 -1,290.000 115.200 -1,330.844
202303 -530.000 116.550 -540.450
202306 -1,231.000 117.140 -1,248.947
202309 -1,166.000 119.111 -1,163.421
202312 -1,483.000 118.848 -1,483.000
202403 516.000 118.848 516.000

Add all the adjusted EPS together and divide 10 will get our e10.


CKD Bio  (XKRX:063160) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

CKD Bio's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=22350.00/227.32
=98.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of CKD Bio was 141.64. The lowest was 10.62. And the median was 27.67.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


CKD Bio E10 Related Terms

Thank you for viewing the detailed overview of CKD Bio's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


CKD Bio (XKRX:063160) Business Description

Traded in Other Exchanges
N/A
Address
368 Chungjeongno 3-ga, Seodaemun-gu, Seoul, KOR, 120-756
CKD Bio Corp is engaged in manufacturing and distribution of pharmaceutical materials and medicines. Its products portfolio include antibiotic, lactamase inhibitors, antituberculosis, antidiabetics, immunosuppressants, antihyperlipidemics, intermediates, and probiotics.

CKD Bio (XKRX:063160) Headlines

No Headlines